Uganda: Cheaper HIV Prevention Drug Coming
New agreements cut the price of HIV prevention drug Lenacapavir from $28,000 to $40 per person annually, potentially preventing millions of infections in low-income countries.
3 Articles
3 Articles
Uganda: Cheaper HIV Prevention Drug Coming
[Independent (Kampala)] Kampala -- THE INDEPENDENT & AGENCIES | A new long-acting medicine that could make preventing HIV transition might soon be even for poor countries like Uganda thanks to agreements between producers and key HIV/AIDS prevention programme advocates.
MSF supports new agreement to increase access to HIV prevention medicine
MSF supports new agreement to increase access to HIV prevention medicine Deal currently leaves out critical countries and neglects people at high risk of contracting HIV. Leila Rafei September 29 2025, 2:29pm However, the licensing agreement currently leaves out various low- and middle-income countries where approximately one quarter of new HIV infections occur.HIV remains a key global public health challenge, with 1.3 million people becoming …
Cheaper HIV prevention drug coming
Drug can be used to prevent catching the virus and treat those who have it Kampala, Uganda | THE INDEPENDENT & AGENCIES | A new long-acting medicine that could make preventing HIV transition might soon be even for poor countries like Uganda thanks to agreements between producers and key HIV/AIDS prevention programme advocates. Lenacapavir, produced by U.S. company Gilead, is a revolutionary new medicine that prevents HIV infection with injection…
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium